Actively Recruiting
Intrathecal Dexmedetomidine With Bupivacaine, in Patients Undergoing Knee Orthopedic Surgery
Led by Cairo University · Updated on 2026-04-13
120
Participants Needed
1
Research Sites
78 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study aims to compare the duration of analgesia (as the primary outcome) and adverse effects (as the secondary outcome) after intrathecal administration of dexmedetomidine with hyperbaric bupivacaine to patients undergoing knee orthopedic surgery.
CONDITIONS
Official Title
Intrathecal Dexmedetomidine With Bupivacaine, in Patients Undergoing Knee Orthopedic Surgery
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age from 18 to 65 years.
- American Society of Anesthesiologists (ASA) physical status I-II.
- Male patients scheduled for knee orthopedic surgery.
You will not qualify if you...
- Patients with psychiatric disorders.
- History of drug addiction.
- Contraindication for regional anesthesia.
- History of hypersensitivity to the study drugs.
- Previous administration of opioids and/or other central nervous system depressants during current hospital admission.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Cairo University
Cairo, Egypt, 12613
Actively Recruiting
Research Team
A
Ahmed A Ismail, MSc
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here